Report - Molecular Tumor Board in Oncology · 2019-04-24 · PD após Docetaxel, Cabazitaxel, Abiraterona, Enzalutamida ... (4/12 LNs) 12.2014 – PSA 2,1. 01.2015 – PSA 5,8. 01.2015 –

Please pass captcha verification before submit form